Analysis of the rate and changes in the incidence of age-related diseases (by medical care uptake) in 2018–2022 (through the example of a municipal hospital in Saint Petersburg)
https://doi.org/10.20538/1682-0363-2024-4-129-135
Abstract
The aim was to study the rate and changes in the incidence (by uptake) of age-related diseases (ARDs) in 2018– 2022 through the example of a municipal hospital in Saint Petersburg.
Materials and methods. The study was carried out on the basis of records and reports for the period of 2018–2022 for the main statistical age groups (adult population (AP), working age population (WAP), persons over working age (POWA)). The incidence was analyzed for the most common ARDs (hypertensive diseases; coronary heart disease; type 2 diabetes mellitus; senile cataract, and glaucoma). The assessment of the incidence rate was carried out both for ARDs in general and for particular diseases.
Results. A long-term observation revealed that the incidence of ARDs has been increasing. In WAP, the rate of the increase in the incidence of ARDs was more pronounced compared to the same indicator in the general population surveyed (16.1 versus 5.4%). Moreover, in the post-COVID period, the incidence rate of a number of ARDs increased. In addition, a regular sequence was found in the manifestation of ARDs: hypertensive diseases, coronary heart disease, type 2 diabetes mellitus, senile cataract, glaucoma.
Conclusion. The incidence rate of age-related diseases has been increasing, which is especially pronounced among WAP. In the post-COVID period, these diseases were found to develop much faster. ARDs are characterized by a sequence of manifestations as patients get older, which in the future will allow to develop clearer approaches to the prevention, diagnosis, and treatment of ARDs depending on the age of the patient.
About the Authors
U. R. Saginbaev
St. Petersburg Institute of Bioregulation and Gerontology
Russian Federation
Russian Federation
3, Dinamo Av., Saint Petersburg, 197110
T. A. Akhmedov
St. Petersburg Institute of Bioregulation and Gerontology
Russian Federation
Russian Federation
3, Dinamo Av., Saint Petersburg, 197110
S. A. Rukavishnikova
St. Petersburg Institute of Bioregulation and Gerontology
Russian Federation
Russian Federation
3, Dinamo Av., Saint Petersburg, 197110
E. P. Davydova
St. Petersburg Institute of Bioregulation and Gerontology
Russian Federation
Russian Federation
3, Dinamo Av., Saint Petersburg, 197110
References
1. Прощаев К.И., Ильницкий А.Н., Жернакова Н.И. Основные гериатрические синдромы: учебное пособие. Белгород, 2012:228.
2. Xia S., Zhang X., Zheng S., Khanabdali R., Kalionis B., Wu J. al. An update on inflamm-aging: mechanisms, prevention and treatment. Journal of Immunology Research. 2016;8:1–12. DOI: 10.1155/2016/8426874.
3. Dartigues J.F., Bourdonnec K.L., Tabue-Teguo M., Le Goff M., Helmer C., Avila-Funes J.A. et al. Co-occurrence of geriatric syndromes and diseases in the general population: assessment of the dimensions of aging. The Journal of Nutrition, Health, Aging. 2022;26(1):37–45. DOI: 10.1007/s12603-021-1722-3.
4. Samieri C., Perier M.C., Gaye B., Proust-Lima C., Helmer C., Dartigues J.F. et al. Association of cardiovascular health level in older age with cognitive decline and incident dementia. JAMA. 2018;320(7):657–664. DOI: 10.1001/jama.2018.11499.
5. Avila-Funes J.A., Pelletier A., Meillon C., Catheline G., Periot O., Trevino-Frenk I. et al. Vascular cerebral damage in frail older adults: the AMImage study. The Journals of Gerontology. 2017;72(7):971–977. DOI: 10.1093/gerona/glw347.
6. Guo X., Franco O.H., Laine J.E. Accelerated ageing in the COVID-19 pandemic: A dilemma for healthy ageing. Maturitas. 2022;157: 8–69. DOI: 10.1016/j.maturitas.2021.12.009.
7. Иваненко А.А., Ушакова О.В. Эпидемиология сахарного диабета 2 типа в г. Комсомольск-на-Амуре. Дальневосточный медицинский журнал. 2011;3:30–32.
8. Басинская Л.А., Комаровских Е.Н., Сахнов С.Н., Заболотний А.Г. Распространенность сахарного диабета первого и второго типов в Краснодарском крае. Бюллетень физиологии и патологии дыхания. 2013;50:126–129.
9. Баланова Ю.А., Шальнова С.А., Имаева А.Э., Капустина А.В., Муромцева Г.А. и др. Распространенность артериальной гипертонии, охват лечением и его эффективность в Российской Федерации (данные наблюдательного исследования ЭССЕ-РФ-2). Рациональная фармакотерапия в кардиологии. 2019;15(4):450–466. DOI: 10.20996/1819-6446-2019-15-4-450-466.
10. Заболеваемость взрослого населения России в 2019 году. Статистические материалы. М.: Минздрав России, 2020:160.
11. Заболеваемость населения старше трудоспособного возраста по России в 2019 году. Статистические материалы. М.: Минздрав России, 2020:183.
12. Здравоохранение в России. 2019: статистический сборник. М.: Росстат, 2019:170.
13. Неудахин Е.В., Морено И.Г. К вопросу о патогенезе атеросклероза и коррекции атерогенных нарушений у детей. РМЖ. Педиатрия. 2018;9:62–68.
Review
For citations:
Saginbaev U.R., Akhmedov T.A., Rukavishnikova S.A., Davydova E.P. Analysis of the rate and changes in the incidence of age-related diseases (by medical care uptake) in 2018–2022 (through the example of a municipal hospital in Saint Petersburg). Bulletin of Siberian Medicine. 2024;23(4):129-135. https://doi.org/10.20538/1682-0363-2024-4-129-135
Views:
135
Email this article 